Quantbot Technologies’s Zevra Therapeutics ZVRA Stock Holding History

Quantbot Technologies’s Portfolio ZVRA Stock Details ZVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-718	Closed	-$6.69K	–	2316
2026 Q1	$6.69K	Buy	+718	New	+$6.47K	﹤0.01%	1562
2025 Q4	–	Sell	-62,646	Closed	-$596K	–	2246
2025 Q3	$596K	Buy	62,646 +33,654	+116%	+$338K	0.02%	958
2025 Q2	$255K	Buy	+28,992	New	+$235K	0.01%	1163
2025 Q1	–	Sell	-13,024	Closed	-$109K	–	1946
2024 Q4	$109K	Sell	13,024 -7,219	-36%	-$61.6K	﹤0.01%	1184
2024 Q3	$140K	Buy	+20,243	New	+$137K	0.01%	1105
2023 Q3	–	Sell	-4,900	Closed	-$25K	–	2035
2023 Q2	$25K	Buy	+4,900	New	+$26.4K	﹤0.01%	1397
2021 Q2	–	Sell	-200	Closed	-$1K	–	1935
2021 Q1	$1K	Buy	+200	New	+$1.75K	﹤0.01%	1351

Other funds holding ZVRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Quantbot Technologies's ZVRA Position: Q2 2026 in Review

Quantbot Technologies sold out of Zevra Therapeutics (ZVRA) in Q2 2026, closing a stake of 718 shares — an estimated $6.69K sold.

Quantbot Technologies first reported a position in ZVRA in Q1 2021 and held it in 7 quarters. The position peaked at $596K in Q3 2025. 157 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

Quantbot Technologies reported no remaining Zevra Therapeutics position as of Q2 2026 after selling out during the quarter.
Quantbot Technologies sold 718 Zevra Therapeutics shares in Q2 2026, an estimated $6.69K.
Quantbot Technologies first reported a position in Zevra Therapeutics in Q1 2021 and held it in 7 quarters.
Quantbot Technologies's Zevra Therapeutics position peaked at $596K in Q3 2025.
157 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.